Offer - Urjas Oil for just ₹ 1 X
StayHappi Terbutaline + Bromhexine + Guaiphensin + Menthol Syrup is an allopathic medicine The correct dosage of StayHappi Terbutaline + Bromhexine + Guaiphensin + Menthol Syrup depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
StayHappi Terbutaline + Bromhexine + Guaiphensin + Menthol Syrup is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of StayHappi Terbutaline + Bromhexine + Guaiphensin + Menthol Syrup safe for pregnant women?
No research has not been done till date on the safety of StayHappi Terbutaline + Bromhexine + Guaiphensin + Menthol Syrup for pregnant women. So its effects on pregnant women are unknown.
Is the use of StayHappi Terbutaline + Bromhexine + Guaiphensin + Menthol Syrup safe during breastfeeding?
There is no research available on the side effects of StayHappi Terbutaline + Bromhexine + Guaiphensin + Menthol Syrup in breastfeeding women. Therefore, its impact is unknown.
What is the effect of StayHappi Terbutaline + Bromhexine + Guaiphensin + Menthol Syrup on the Kidneys?
StayHappi Terbutaline + Bromhexine + Guaiphensin + Menthol Syrup does not damage the kidneys.
What is the effect of StayHappi Terbutaline + Bromhexine + Guaiphensin + Menthol Syrup on the Liver?
StayHappi Terbutaline + Bromhexine + Guaiphensin + Menthol Syrup is not harmful for the liver.
What is the effect of StayHappi Terbutaline + Bromhexine + Guaiphensin + Menthol Syrup on the Heart?
There are no any side effects of StayHappi Terbutaline + Bromhexine + Guaiphensin + Menthol Syrup for the heart.
StayHappi Terbutaline + Bromhexine + Guaiphensin + Menthol Syrup should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take StayHappi Terbutaline + Bromhexine + Guaiphensin + Menthol Syrup unless your doctor advises you to do so -
Is this StayHappi Terbutaline + Bromhexine + Guaiphensin + Menthol Syrup habit forming or addictive?
StayHappi Terbutaline + Bromhexine + Guaiphensin + Menthol Syrup does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking StayHappi Terbutaline + Bromhexine + Guaiphensin + Menthol Syrup, you should not drive or work on any heavy machine, as StayHappi Terbutaline + Bromhexine + Guaiphensin + Menthol Syrup can make you drowsy.
Is it safe?
Yes, but consume StayHappi Terbutaline + Bromhexine + Guaiphensin + Menthol Syrup only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking StayHappi Terbutaline + Bromhexine + Guaiphensin + Menthol Syrup for mental disorders.
Interaction between Food and StayHappi Terbutaline + Bromhexine + Guaiphensin + Menthol Syrup
Taking StayHappi Terbutaline + Bromhexine + Guaiphensin + Menthol Syrup with food is safe.
Interaction between Alcohol and StayHappi Terbutaline + Bromhexine + Guaiphensin + Menthol Syrup
Consult your doctor before consuming alcohol while taking StayHappi Terbutaline + Bromhexine + Guaiphensin + Menthol Syrup as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 888
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1182-1183
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Guaifenesin
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 629-631
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 219
Product Description [Internet]: BRO-ZEDEX. Wockhardt Ltd
Product Description [Internet]: BENYLIN. Mcneil
Package Leaflet [Internet]: BRICANYL. Astrazeneca
Product Description [Internet]: ROBITUSSIN. Pfizer
Product Description [Internet]: BISOLVON®. Boehringer Ingelheim